Hello, my name is Kai Henrikson-Brandt

I am a current sophomore at Johns Hopkins University studying Chemical & Biomolecular Engineering. I am on the Data Science & Machine Learning track and plan a minor in Entrepreneurship & Management. I am also a member of Johns Hopkins Swimming. This repo functions both as a centralized portfolio and as a space for me to organize my thoughts and notes on a variety of topics including the life sciences, engineering, business, but also philosophy, literature, and other miscellaneous reflections.

Repository Layout

archive/
├── biopharma_biotech/
│   ├── r&d/
│   └── business/
├── engineering/
├── misc/
│   ├── career/
│   ├── philosophy/
│   └── reading/
├── portfolio/
└── README.md

Current Interests

My outlook today is broad. After a summer bridging computational and wet-lab therapeutic peptide research, I find myself with hardly more clarity of what I want to do (or, perhaps more importantly, what I don't want to do) in the future. Today, therapeutic development continues to interest me, but the day-to-day of R&D left me with an itch for adding high-level, top-down strategy thinking, at least in the long-term. At Hopkins this year, I look forward to continue work both in therapeutic development, with particular interest in protein engineering, radiopharmaceuticals, and immunotherapy, and from Genauris on the business, strategy, and operations side of healthcare and the life sciences. In the future, I hope to combine these interests, hopefully striking an intellectually stimulating bridge between driving innovation and the decisions that bring those innovations to fruition.

Experience

Financial Analyst & Strategy Intern - Genauris

Part-Time, January 2026 - Present

• Audited and restructured a 5-year operational P&L, synchronizing downstream labor, OPEX, and COGS forecasts across 7 global business units.
• Implemented dynamic scaling assumptions linking operational headcount to active user growth, preserving modeled cash runway during variable adoption.

Medicinal Chemistry Intern - NIH/NCATS (National Center for Advancing Translational Sciences)

Full-Time, June 2026 - August 2026

• Architected an end-to-end computational generation pipeline for optimized peptide analogs, incorporating biophysical and structural filters to reduce a candidate pool of 5,000 to 8 for synthesis.
• Managed the synthesis, resin cleavage, isolation, and characterization of analog peptides, driving the lead optimization process downstream to ADME, in vitro binding, and in vivo efficacy assays for promising candidates.